annb0t
Top 20
Immutep Limited
Agreement with FDA on Phase II/III trial design positions the Company to exploit eftilagimod alphaâs potential to address high unmet need for metastatic breast cancer patients Patient population expanded to include patients with triple-negative breast cancer Late-stage clinical development efforts remain focused on frontline non-small cell lung cancer (NSCLC) in combination with anti-PD-1 therapy Immutepâs cash runway extended to the end of the 1st half of calendar yea...
>>> Read more: Immutep Announces Successful Meeting with the FDA on Eftilagimod Alpha plus Chemotherapy for the Treatment of Metastatic Breast Cancer
Agreement with FDA on Phase II/III trial design positions the Company to exploit eftilagimod alphaâs potential to address high unmet need for metastatic breast cancer patients Patient population expanded to include patients with triple-negative breast cancer Late-stage clinical development efforts remain focused on frontline non-small cell lung cancer (NSCLC) in combination with anti-PD-1 therapy Immutepâs cash runway extended to the end of the 1st half of calendar yea...
>>> Read more: Immutep Announces Successful Meeting with the FDA on Eftilagimod Alpha plus Chemotherapy for the Treatment of Metastatic Breast Cancer
